BATS BZX Real-Time Price
As of 12:00pm ET
| -0.17 / -1.94%|
The 9 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +51.16% increase from the last price of 8.60.
The current consensus among 9 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.